Skip to main content

Month: August 2025

IQST – IQSTEL and Cycurion (CYCU) Sign MOU for Equity Exchange and Alliance to Build a Next-Gen AI-Driven Powerhouse with Half of the Stock to be Distributed as a Dividend to Shareholders

Both Companies combined have Invested Millions of Dollars over the last 5 years into Proprietary AI assets and technologies. NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — IQSTEL Inc. (NASDAQ: IQST) (“IQSTEL”) and Cycurion Inc. (NASDAQ: CYCU) (“Cycurion”) today announced the signing of a Memorandum of Understanding (MOU) to become mutual equity partners following a planned $1 million stock exchange, with half of each company’s exchanged shares to be distributed as a dividend to enhance shareholder value. This milestone marks a significant step in the two companies’ collaboration and sets the stage for creating a powerhouse in AI-driven cybersecurity for the global telecommunications industry. This transaction is designed to unlock shareholder value, while being strategically timed for both companies as the products and services of...

Continue reading

PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights

PMV will host an investor webinar on Wednesday, September 10, 2025 at 8:00 AM ET to review Phase 2 PYNNACLE clinical trial interim analysis    Interim analysis will include data for approximately 65 patients with at least 18 weeks of follow-up  Cash, cash equivalents, and marketable securities of $148.3 million as of June 30, 2025, providing expected cash runway to end of 2026PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the second quarter ended June 30, 2025, and provided a corporate update. PMV Pharma will host an investor webinar on Wednesday, September 10, 2025 at 8:00 AM ET to review...

Continue reading

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through system upgrades and localization NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary, unaudited revenue results and key operational highlights for the fiscal fourth quarter and full-year ended June 30, 2025. “Fiscal 2025 represented a year of disciplined execution and strategic investment. For the fiscal fourth quarter, we expect to report another quarter of sequential and year-over-year...

Continue reading

NetworkNewsAudio Announces Audio Press Release (APR) on Expanding Neural Tech Leadership in Booming AI Wearables Market

AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) —  via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Neural Tech Drives the Growth of the AI Wearables Market,” featuring Wearable Devices Ltd. (NASDAQ: WLDS). To hear the NetworkNewsAudio version, visit https://nnw.fm/Cr4Sz To read the original editorial, visit https://nnw.fm/OZmoJ Wearable Devices Ltd. is emerging as a leading innovator in the rapidly expanding AI-powered wearables sector, which is projected to grow from $21.2 billion in 2022 to over $260 billion by 2032. At the heart of the company’s offering is its proprietary neural input technology, including the Mudra Link wristband and the LMM platform, which enable intuitive, touchless control of digital devices through subtle wrist signals. These innovations support hands-free interaction with AR/VR...

Continue reading

SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification

–        Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events        – NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the Independent Data Monitoring Committee (IDMC) has completed a pre-specified analysis of the Phase 3 REGAL trial of galinpepimut-S (GPS) in acute myeloid leukemia (AML), and has issued a positive recommendation to continue the trial without modification. The IDMC concluded that the risk-benefit profile of GPS supports continued evaluation under the current study protocol. No safety concerns were identified, and available efficacy data were consistent with expectations...

Continue reading

Aureus Greenway Holdings , Inc. Regains Compliance with Nasdaq Minimum Bid Price Rule

Kissimmee, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Aureus Greenway Holdings Inc. (the “Company”, “Aureus Greenway”, “we”, “us”, “our”) (Nasdaq: AGH), an owner and operator of daily fee golf country clubs in the state of Florida, announced today that on August 6, 2025, the Company received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that for the ten consecutive business days from June 23, 2025, to August 5, 2025, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, Aureus Greenway has regained compliance with Nasdaq Listing Rule 5550(a)(2). About Aureus Greenway Holdings Inc. Aureus Greenway Holdings Inc. (Nasdaq: AGH), owns and operates daily fee golf country clubs in the state of Florida that are designed to appeal to a wide-ranging population. The...

Continue reading

Enact Receives Ratings Upgrade from Moody’s

Fourth Moody’s Upgrade Since IPO Reflects Enact’s Financial Discipline and Capital Strength RALEIGH, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that Moody’s Investor Service (“Moody’s”) upgraded the insurance financial strength rating for our flagship insurance subsidiary, Enact Mortgage Insurance Corporation, to A2 from A3. Moody’s also announced the upgrade of Enact Holdings, Inc.’s long-term issuer rating and senior unsecured debt rating to Baa2 from Baa3. The outlook for the ratings is stable. “This represents Enact’s fourth upgrade from Moody’s since our IPO in 2021,” said Rohit Gupta, Enact’s President and Chief Executive Officer. “This milestone reflects our disciplined execution and...

Continue reading

Trump Media Launches Great American Media Video Catalogue

Great American Library Leads Expansion of Truth+ On-Demand Content SARASOTA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“Trump Media” or the “Company”), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that Truth+ has launched a slate of on-demand content from the Great American Media broadcaster. The offering, which includes faith-based programming along with family-friendly movies, documentaries, and TV shows, will be available to subscribers of the Truth+ Patriot Package. The catalogue of curated content available on the Truth+ Patriot Package is expected to be updated with thousands of additional hours of content from Great American and other premium broadcasters. Great...

Continue reading

ZenaTech Acquires Cardinal Civil Resources, a Virginia-Based Land Surveying and Engineering Firm Serving Three States and Large Customers Including US Department of Transportation

VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-powered drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the closing of its eighth and largest Drone as a Service acquisition to date. The Company acquired Cardinal Civil Resources, a land surveying and engineering firm headquartered in Williamsburg, Virginia with operations across Virginia, North Carolina and South Carolina. The acquisition deepens ZenaTech’s DaaS footprint in the Southeast region and portfolio of marquee major customers including the US Department of Transportation (USDOT). The acquisition also comes at a pivotal time for the domestic drone industry, aligning with...

Continue reading

One Stop Systems Reports Q2 2025 Results

Second quarter of 2025 consolidated gross margin increased over 600 basis points year-over-year to 31.3%, on consolidated revenue of $14.1 million OSS segment gross margin of 41.3%, on OSS segment revenue of $5.8 million Year-to-date OSS segment bookings of $25.4 million, supports outlook for accelerating revenue growth and improving profitability for the second half of 2025 ESCONDIDO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML), autonomy and sensor processing at the edge, reported results for the second quarter ended June 30, 2025. Second-quarter and six-month comparisons are to the same year-ago periods unless otherwise noted. “The performance of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.